Two novel variants in the DOPA decarboxylase gene: Association with bipolar affective disorder

Molecular Psychiatry

Volumn 4, Issue 6, 1999, Pages 545-551

  Borglum A D ^c   Bruun, T G ^d   Kjeldsen, T E ^d   Ewald, H ^d   Mors, O ^d   Kirov, G ^a   Russ, C ^b   Freeman, B ^b   Collier, D A ^b   Kruse, T A ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

^d NONE

Author keywords

AADC; BPAD; Complex disorder; DDC; Gene variants

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; DOPAMINE; NEUROTRANSMITTER; NORADRENALIN; SEROTONIN; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; CODING; CONTROLLED STUDY; DOPAMINE METABOLISM; EXON; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; SEQUENCE ANALYSIS;

EID: 0032755352     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000559     Document Type: Article

References (55)

1. 1 Goodwill FK, Jamison KR. Biochemical and pharmacological studies. In: Goodwin FK, Jamison KR (eds). Manic-depressive Illness. Oxford University Press: New York, 1990, pp 416-502.
2. 2 Tsuang MT, Faraone SV. The Genetics of Mood Disorders. The John Hopkins University Press: Baltimore, London, 1990.
3. 3 Lander ES, Schork NJ. Genetic: dissection of complex traits [published erratum appears in Science 1934: 266: 353]. Science 1994; 265: 2037-2048.
4. 4 Strittmatter WJ, Saunders AM, Schmechel D, Pericak Vance M, Enghild J, Salvesen GS et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
5. 5 Ryder LP, Andersen E, Svejgaard A. HLA and Disease Registry, Third Report. Munksgaard: Copenhagen, 1979.
6. 6 Leboyer M, Malafosse A, Boularand S, Campion D, Gheysen F, Samolyk D et al. Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet 1990; 335: 1219.
7. 7 Meloni R, Leboyer M, Bellivier F, Barbe B, Samolyk D, Allilaire JF et al. Association of manic-depressive illness with tyrusine hydroxylase microsatellite marker. Lancet 1995; 345: 932.
8. 8 Lim LC, Powell JF, Murray R, Gill M. Monoamine oxidase A gene and bipolar affective disorder. Am J Hum Genet 1994; 54: 1122-1124.
9. 9 Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P et al. The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Neuroreport 1996; 7: 1675-1679.
10. 10 Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 1996; 347: 731-733.
11. 11 Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 1998; 55: 33-37.
12. 12 Owens MJ, Nemeroff CB. Rule of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 1994; 40: 288-295.
13. 13 van Praag HM, Korf J, Puite J. 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 1970; 225: 1259-1260.
14. 14 Meas M, Melzer HY. The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology: The Fourth Generation in Progress. Raven Press: New York, 1995, pp 933-943.
15. 15 Samson JA, Gudeman JE, Schatzberg AF, Kizuka PP, Orsulak PJ, Cole JO et al. Toward a biochemical classification of depressive disorders-VIII. Platelet monoamine oxidase activity in subtypes of depressions. J Psychiatr Res 1985; 19: 547-555.
16. 16 Christenson JG, Dairman W, Udenfriend S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic L-amino acid decarboxylase-serotonin-dopamine-norepinephrine). Proc Natl Acad Sci USA 1972; 69: 343-347.
17. 17 Bowsher RR, Henry DP. Aromatic L-amino acid decarboxylase: biochemistry and functional significance. In: Boulton AA, Baker GB, Yu PH (eds). Neuromethods: Series I: Neurochemistry, Neurotransmitter Enzymes. Humana Press: Clifton, Now Jersey, 1986, pp 33-77.
18. 18 Zhu MY, Juorio AV. Aromatic L-amino acid decarboxylase: biological characterization and functional role. Gen Pharmacol 1995; 26: 681-696.
19. 19 Boulton AA. Cerebral aryl alkyl aminergic mechanisms. In: Usdin E, Sandler M (eds). Trace Amines in the Brain. Marcel Dekker: New-York, 1976, pp 21-39.
20. 20 Paterson IA, Juorio AV, Boulton AA. 2-Phenylethylamine: a modulator of catocholamine transmission in the mammalian central nervous system? J Neurochem 1990; 55: 1827-1837.
21. 21 Juorio AV, Paterson IA. Tryptamine may couple dopaminergic and serotonergic transmission in the brain. Gen Pharmacol 1990; 21: 613-616.
22. 22 Scherer LJ, McPherson JD, Wasmuth JJ, Marsh JL. Human dopa decarboxylase: localization to human chromosome 7p11 and characterization of hepatic cDNAs. Genomics 1992; 13: 469-471.
23. 23 Sumi-Ichinose G, Ichinose H, Takahashi E, Hori T, Nagatsu T. Molecular cloning of genomic DNA and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 1992; 31: 2229-2238.
24. 24 Craig SP, Thai AL, Weber M, Craig IW. Localisation of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13 → p11 by in situ hybridisation. Cytogenet Cell Genet 1992; 61: 114-116.
25. 25 Le Van Thai A, Caste E, Allen JM, Palmiter RD, Weber MJ. Identification of a neuron-specific promoter of human aromatic L-amino acid decarboxylase gene. Brain Res Mol Brain Res 1993; 17: 227-238.
26. 26 Chireux M, Raynal JF, Le Van Thai A, Cadas H, Bernard C, Martinou T et al. Multiple promoters of human choline acetyltransferase and aromatic L-amino acid decarboxylase genes. J Physiol Paris 1994; 88: 215-227.
27. 27 Sumi-Ichinose C, Hasegawa S, Ichinose H, Sawada H, Kobayashi K, Sakai M et al. Analysis of the alternative promoters that regulate tissue-specific expression of human aromatic L-amino acid decarboxylase. J Neurochem 1995; 64: 514-524.
28. 28 Sumi-Ichinose C, Hasegawa S, Ohtsuki M, Nomura H, Nomura T, Hagino Y et al. Analysis of an alternative promoter that regulates tissue-specific expression of the human aromatic L-amino acid decarboxylase gene in cultured cell lines. J Neural Transm 1990; 103: 1-15.
29. 29 Berry MD, Juorio AV, Li XM, Boulton AA. Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res 1996; 21: 1075-1087.
30. 30 World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (SCAN version 2.1). World Health Organization: Geneva, 1996.
31. 31 World Health Organization. The JCD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. World Health Organization: Geneva, 1993.
32. 32 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva, 1992.
33. 33 American Psychiatric Association CoNaS. Diagnostic and Statistical Manual of Mental Disorders (Fourth edn). American Psychiatric Association: Washington DC, 1994.
34. 34 Gershon ES, Guroff JJ. Information from relatives. Diagnosis of affective disorders. Arch Gen Psychiatry 1984; 41: 173-180.
35. 35 Leckman JF, Sholomskas D, Thompson WD, Belanger A, Weissman MM. Best eslimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 1982; 39: 879-883.
36. 36 McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRTT system. Arch Gen Psychiatry 1991; 48: 764-770.
37. 37 Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ et al. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 1977; 74: 1245-1249.
38. 38 Sanger F, Nicklen S, Coulson AR. DNA sequencing with chainterminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-5467.
39. 39 Maniatis T, Hardison RC, Lacy E, Lauer J, O'Connell C, Quon D et al. The isolation of structural genes from libraries of eucaryotic DNA. Cell 1978; 15: 687-701.
40. 40 Terwilliger JD, Ott J. Handbook of Human Genetic Linkage. The Johns Hopkins University Press: Baltimore, London, 1994.
41. 41 Swirnoff AH, Milbrandt J. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol Cell Biol 1995; 15: 2275-2287.
42. 42 Ichinose H, Kurosawa Y, Titani K, Fujita K, Nagatsu T. Isolation and characterization of a cDNA clone encoding tinman aromatic L-amino acid decarboxylase. Biochem Biophys Res Commun 1989; 164: 1024-1030.
43. 43 Wilkins KC, Lis JT. Dynamics of potentiation and activation: GAGA factor and its role in heat shock gene regulation. Nucleic Acids Res 1997; 25: 3963-3968.
44. 44 Wilkins RC, Lis JT. GAGA factor binding to DNA via a single trinucleotide sequence element. Nucleic Acids Res 1998; 26: 2672-2678.
45. 45 Holmes G, Lovestone S. The molecular genetics of mood disorders. Curr Opin Psychiatry 1997; 10: 79-83.
46. 46 Risch N, Botstein D. A manic depressive history. Nat Genet 1996; 12: 351-353.
47. 47 Vieland VJ, Hodge SE. Statistical Evidence: A Likelihood Paradigm, by Richard Royall (review). Am J Hum Gennet 1998; 63: 283-289.
48. 48 Ewald H, Mors O, Eiberg H, Flint T, Kruse TA. No evidence of linkage between manic depressive illness and the dopa decarboxylase gene or nearby region on chromosome 7p. Psychiatr Genet 1995; 5: 161-169.
49. 49 Greenberg DA. Linkage analysis of 'necessary' disease loci versus 'susceptibility' loci. Am J Hum Genet 1993; 52: 135-143.
50. 50 Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
51. 51 Ernø H, Kury P, Botteri FM, Monard D. A Krox binding site regulates protease nexin-1 promoter activity in embryonic heart, cartilage and parts of the nervous system. Mech Dev 1996; 60: 139-150.
52. 52 Bertelsen A, Harvald B, Hauge M. A Danish twin study of manic-depressive disorders. Br J Psychiatry 1977; 130: 330-351.
53. 53 Tsuang MT, Winokur G, Crowe RR. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression and surgical conditions. Br J Psychiatry 1980; 137: 407-504.
54. 54 Gershon ES, Hamovit J, Guroff JJ, Dibble E, Leckman JF, Sceery W et al. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch Gen Psychiatry 1982; 39: 1157-1167.
55. 55 Weissman MM, Gershon ES, Kidd KK, Prusoff BA, Leckman JF, Dibble E et al. Psychiatric disorders in the relatives of probands with affective disorders. The Yale University-National Institute of Mental Health Collaborative Study. Arch Gen Psychiatry 1984; 41: 13-21.